Thirty-three out of the 43 cases (76.7%) of patients with ovarian cancer examined had positive claudin-4 expression with a significant shorter survival noted in the claudin-4 positive versus claudin-4 negative group [98]. The gene discussed is CLDN4; the disease is ovarian carcinoma.